19 related articles for article (PubMed ID: 3516593)
1. Dual beta-lactam treatment: Pros and cons.
Guerra D; Vidal P; Paccoud O; Maillard A; Cachera L; Junot H; Gauzit R; Zahar JR; Abreu MA; Bleibtreu A
Porto Biomed J; 2022; 7(5):e189. PubMed ID: 37213916
[TBL] [Abstract][Full Text] [Related]
2. Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora.
Stark C; Edlund C; Hedberg M; Nord CE
Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):18-24. PubMed ID: 7729448
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
Livermore DM
Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
[TBL] [Abstract][Full Text] [Related]
4. In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
Miller MA; Finan M; Yousuf M
J Antimicrob Chemother; 1983 Apr; 11(4):311-8. PubMed ID: 6343337
[TBL] [Abstract][Full Text] [Related]
5. Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.
Papanicolaou GA; Medeiros AA
Diagn Microbiol Infect Dis; 1991; 14(1):85-7. PubMed ID: 2013214
[TBL] [Abstract][Full Text] [Related]
6. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
Hechler U; van den Weghe M; Martin HH; Frère JM
J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
[TBL] [Abstract][Full Text] [Related]
7. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
Ramadan MA; Tawfik AF; Shibl AM
Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
[TBL] [Abstract][Full Text] [Related]
8. Interaction of mezlocillin and cefoxitin against Proteus morganii in the granuloma pouch model.
Dalhoff A
Eur J Clin Microbiol; 1982 Aug; 1(4):243-7. PubMed ID: 6217067
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial antagonism of beta-lactam antibiotics in experimental infections.
Kasai K
Chemotherapy; 1986; 32(2):148-58. PubMed ID: 3516593
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and laboratory significance of inducible beta-lactamases].
Bedenić B; Zagar Z
Lijec Vjesn; 1995; 117(9-10):249-53. PubMed ID: 8643019
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
